Division of Gastroenterology and Hepatology, Davis, California.
Department of Medical Microbiology and Immunology, Genome Center, Davis, California.
Cell Mol Gastroenterol Hepatol. 2021;12(4):1457-1477. doi: 10.1016/j.jcmgh.2021.05.020. Epub 2021 Jun 4.
BACKGROUND & AIMS: The pathogenesis of Wilson disease (WD) involves hepatic and brain copper accumulation resulting from pathogenic variants affecting the ATP7B gene and downstream epigenetic and metabolic mechanisms. Prior methylome investigations in human WD liver and blood and in the Jackson Laboratory (Bar Harbor, ME) C3He-Atp7b/J (tx-j) WD mouse model revealed an epigenetic signature of WD, including changes in histone deacetylase (HDAC) 5. We tested the hypothesis that histone acetylation is altered with respect to copper overload and aberrant DNA methylation in WD.
We investigated class IIa HDAC4 and HDAC5 and H3K9/H3K27 histone acetylation in tx-j mouse livers compared with C3HeB/FeJ (C3H) control in response to 3 treatments: 60% kcal fat diet, D-penicillamine (copper chelator), and choline (methyl group donor). Experiments with copper-loaded hepatoma G2 cells were conducted to validate in vivo studies.
In 9-week tx-j mice, HDAC5 levels increased significantly after 8 days of a 60% kcal fat diet compared with chow. In 24-week tx-j mice, HDAC4/5 levels were reduced 5- to 10-fold compared with C3H, likely through mechanisms involving HDAC phosphorylation. HDAC4/5 levels were affected by disease progression and accompanied by increased acetylation. D-penicillamine and choline partially restored HDAC4/5 and H3K9ac/H3K27ac to C3H levels. Integrated RNA and chromatin immunoprecipitation sequencing analyses revealed genes regulating energy metabolism and cellular stress/development, which, in turn, were regulated by histone acetylation in tx-j mice compared with C3H mice, with Pparα and Pparγ among the most relevant targets.
These results suggest dietary modulation of class IIa HDAC4/5, and subsequent H3K9/H3K27 acetylation/deacetylation can regulate gene expression in key metabolic pathways in the pathogenesis of WD.
威尔逊病(WD)的发病机制涉及肝脏和大脑铜积累,这是由影响 ATP7B 基因及其下游表观遗传和代谢机制的致病性变异引起的。先前在人类 WD 肝脏和血液以及杰克逊实验室(缅因州巴港)C3He-Atp7b/J(tx-j)WD 小鼠模型中的甲基组学研究揭示了 WD 的表观遗传特征,包括组蛋白去乙酰化酶(HDAC)5 的变化。我们检验了 WD 中铜过载和异常 DNA 甲基化与组蛋白乙酰化改变相关的假说。
我们研究了 tx-j 小鼠肝脏中的 IIa 类 HDAC4 和 HDAC5 以及 H3K9/H3K27 组蛋白乙酰化,与 C3HeB/FeJ(C3H)对照相比,分别在 3 种处理下:60%热量脂肪饮食、D-青霉胺(铜螯合剂)和胆碱(甲基供体)。对负载铜的肝癌 G2 细胞进行了实验,以验证体内研究。
在 9 周龄 tx-j 小鼠中,与对照饮食相比,60%热量脂肪饮食 8 天后 HDAC5 水平显著升高。在 24 周龄 tx-j 小鼠中,HDAC4/5 水平降低了 5-10 倍,可能通过涉及 HDAC 磷酸化的机制。HDAC4/5 水平受疾病进展影响,并伴有乙酰化增加。D-青霉胺和胆碱部分将 HDAC4/5 和 H3K9ac/H3K27ac 恢复至 C3H 水平。RNA 和染色质免疫沉淀测序分析的整合揭示了调节能量代谢和细胞应激/发育的基因,这些基因在 tx-j 小鼠中受组蛋白乙酰化调节,与 C3H 小鼠相比,Pparα 和 Pparγ 是最相关的靶标之一。
这些结果表明,IIa 类 HDAC4/5 的饮食调节,以及随后的 H3K9/H3K27 乙酰化/去乙酰化,可以调节 WD 发病机制中关键代谢途径的基因表达。